Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenazopyridine for Pain Following Urodynamics
NCT06577493Phase 4Active, not recruiting
- Sponsor
- University of South Florida
- Start
- Dec 2024
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of phenazopyridine in pain (2 arms), sponsored by University of South Florida. Primary endpoint: Pain Score. Started Dec 2024; status: active, not recruiting.
02
Drugs
phenazopyridine
03
Conditions
pain
Beyond the preview
Go deeper on NCT06577493.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06577493.